Clinical Trial Update: Vericiguat and Reverse Remodeling Indices in Heart Failure [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates vericiguat and reverse remodeling indices in heart failure with reduced ejection fraction and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure | Phase 4 | Status: RECRUITING